LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 101 of 166
Next
>>
>
2501 to 2525 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	LDN-193189	3.33	uM	LJP5	72	hr	1334	1491	4033	0.3698	0.0714
BT-20	LDN-193189	10	uM	LJP5	72	hr	1334	515	4033	0.1278	-0.4497
BT-20	PF431396	0.04	uM	LJP5	72	hr	1334	3745	4033	0.9294	0.9107
BT-20	PF431396	0.12	uM	LJP5	72	hr	1334	3260	4033	0.8082	0.7498
BT-20	PF431396	0.37	uM	LJP5	72	hr	1334	2339	4033	0.5803	0.4218
BT-20	PF431396	1.11	uM	LJP5	72	hr	1334	1342	4033	0.3331	0.0036
BT-20	PF431396	3.33	uM	LJP5	72	hr	1334	1125	4033	0.2794	-0.1013
BT-20	PF431396	10	uM	LJP5	72	hr	1334	571	4033	0.1415	-0.4131
BT-20	Celastrol	0.04	uM	LJP6	72	hr	1334	4023	3925	1.0251	1.0321
BT-20	Celastrol	0.12	uM	LJP6	72	hr	1334	4099	3925	1.0444	1.0566
BT-20	Celastrol	0.37	uM	LJP6	72	hr	1334	3678	3925	0.9370	0.9175
BT-20	Celastrol	1.11	uM	LJP6	72	hr	1334	3231	3925	0.8234	0.7650
BT-20	Celastrol	3.33	uM	LJP6	72	hr	1334	1146	3925	0.2918	-0.0946
BT-20	Celastrol	10	uM	LJP6	72	hr	1334	570	3925	0.1452	-0.4216
BT-20	SU11274	0.04	uM	LJP5	72	hr	1334	4275	4033	1.0599	1.0741
BT-20	SU11274	0.12	uM	LJP5	72	hr	1334	4234	4033	1.0510	1.0639
BT-20	SU11274	0.37	uM	LJP5	72	hr	1334	4098	4033	1.0164	1.0203
BT-20	SU11274	1.11	uM	LJP5	72	hr	1334	3767	4033	0.9348	0.9177
BT-20	SU11274	3.33	uM	LJP5	72	hr	1334	3456	4033	0.8577	0.8168
BT-20	SU11274	10	uM	LJP5	72	hr	1334	1289	4033	0.3199	-0.0215
BT-20	Canertinib	0.04	uM	LJP6	72	hr	1334	3494	3925	0.8907	0.8557
BT-20	Canertinib	0.12	uM	LJP6	72	hr	1334	3574	3925	0.9105	0.8829
BT-20	Canertinib	0.37	uM	LJP6	72	hr	1334	3516	3925	0.8956	0.8628
BT-20	Canertinib	1.11	uM	LJP6	72	hr	1334	3479	3925	0.8863	0.8503
BT-20	Canertinib	3.33	uM	LJP6	72	hr	1334	3276	3925	0.8344	0.7794

|<
<<
Previous
Page 101 of 166
Next
>>
>
2501 to 2525 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)